Cancer Chemotherapy and Pharmacology View Homepage


Ontology type: schema:Periodical     


Journal Info

START YEAR

1978

PUBLISHER

Springer Berlin Heidelberg

LANGUAGE

en

HOMEPAGE

http://link.springer.com/journal/280

Recent publications latest 20 shown

  • 2019-04-12 Neoadjuvant chemotherapy in patients with advanced endometrial cancer.
  • 2019-04-12 Efficacy of immunotherapy, gut microbiota and impact of antibiotic use: are there confounding factors?
  • 2019-04-11 Modeling long-term tumor growth and kill after combinations of radiation and radiosensitizing agents.
  • 2019-04-11 Pharmacokinetic and exploratory exposure-response analysis of pertuzumab in patients with operable HER2-positive early breast cancer in the APHINITY study.
  • 2019-04-10 Investigation of anti-tumor effect of doxorubicin-loaded human serum albumin nanoparticles prepared by a desolvation technique.
  • 2019-04-09 Equipotent doses of daunorubicin and idarubicin for AML: a meta-analysis of clinical trials versus in vitro estimation.
  • 2019-04-09 Comparison of two different carboplatin and weekly paclitaxel schedule in elderly advanced non-small cell lung cancer patients.
  • 2019-04-09 Rabeprazole intake does not affect systemic exposure to capecitabine and its metabolites, 5'-deoxy-5-fluorocytidine, 5'-deoxy-5-fluorouridine, and 5-fluorouracil.
  • 2019-04-09 Docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy for patients with cervical esophageal cancer: a single-center retrospective study.
  • 2019-04-08 De-escalated neoadjuvant therapy with nanoparticle albumin-bound paclitaxel and trastuzumab for low-risk pure HER2 breast cancer.
  • 2019-04-08 Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy: a multicenter, prospective, and observational study.
  • 2019-04-06 Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain.
  • 2019-04-04 An open label phase 1 study evaluation safety, tolerability, and maximum tolerated dose of oral administration of irinotecan in combination with capecitabine.
  • 2019-04 d-dimer increase: an unfavorable factor for patients with primary liver cancer treated with TACE
  • 2019-04 Blockade of integrin β3 signals to reverse the stem-like phenotype and drug resistance in melanoma
  • 2019-04 Upregulation of MTA1 expression by human papillomavirus infection promotes CDDP resistance in cervical cancer cells via modulation of NF-κB/APOBEC3B cascade
  • 2019-04 Molecular targeting of HER2-overexpressing biliary tract cancer cells with trastuzumab emtansine, an antibody–cytotoxic drug conjugate
  • 2019-04 Pharmacokinetic and cytokine profiles of melanoma patients with dabrafenib and trametinib-induced pyrexia
  • 2019-04 Changes in skeletal muscle area and lean body mass during pazopanib vs sunitinib therapy for metastatic renal cancer
  • 2019-04 Prognostic impact of polypharmacy and drug interactions in patients with advanced cancer
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/H33160", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Oncology", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/B21007", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Pharmacology/Toxicology", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/B11001", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Cancer Research", 
            "type": "DefinedTerm"
          }
        ], 
        "contentRating": [
          {
            "author": "snip", 
            "ratingValue": "0.899", 
            "type": "Rating"
          }, 
          {
            "author": "sjr", 
            "ratingValue": "1.147", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2017", 
            "ratingValue": "2.808", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2016", 
            "ratingValue": "2.737", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2016", 
            "ratingValue": "2.737", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2015", 
            "ratingValue": "2.824", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2015", 
            "ratingValue": "2.824", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2014", 
            "ratingValue": "2.769", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2014", 
            "ratingValue": "2.769", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2013", 
            "ratingValue": "2.571", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2013", 
            "ratingValue": "2.571", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2010", 
            "ratingValue": "2.759", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2010", 
            "ratingValue": "2.759", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2009", 
            "ratingValue": "2.654", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2012", 
            "ratingValue": "2.795", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2012", 
            "ratingValue": "2.795", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2011", 
            "ratingValue": "2.833", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2011", 
            "ratingValue": "2.833", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2009", 
            "ratingValue": "2.654", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2008", 
            "ratingValue": "2.740", 
            "type": "Rating"
          }
        ], 
        "description": "

    Cancer Chemotherapy and Pharmacology addresses a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels. The primary focus of this rapid publication medium is on new anticancer agents, their experimental screening, preclinical toxicology and pharmacology, single and combined drug administration modalities, and clinical phase I, II and III trials.

    The journal publishes results recorded in the following areas: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy. Cancer Chemotherapy and Pharmacology is essential reading for pharmacologists and oncologists.

    ", "editor": [ { "familyName": "Sausville", "givenName": "Edward A.", "type": "Person" } ], "id": "sg:journal.1088364", "inLanguage": [ "en" ], "isAccessibleForFree": false, "issn": [ "0344-5704", "1432-0843" ], "license": "Hybrid (Open Choice)", "name": "Cancer Chemotherapy and Pharmacology", "productId": [ { "name": "scopus_id", "type": "PropertyValue", "value": [ "29097" ] }, { "name": "wos_id", "type": "PropertyValue", "value": [ "0344-5704/CANCER CHEMOTHERAPY AND PHARMACOLOGY" ] }, { "name": "nlm_unique_id", "type": "PropertyValue", "value": [ "7806519" ] }, { "name": "nsd_ids_id", "type": "PropertyValue", "value": [ "340159" ] }, { "name": "springer_id", "type": "PropertyValue", "value": [ "280" ] }, { "name": "lccn_id", "type": "PropertyValue", "value": [ "sn 80001635" ] }, { "name": "dimensions_id", "type": "PropertyValue", "value": [ "88364" ] }, { "name": "era_ids_id", "type": "PropertyValue", "value": [ "14707" ] } ], "publisher": { "name": "Springer Berlin Heidelberg", "type": "Organization" }, "publisherImprint": "Springer", "sameAs": [ "https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1088364" ], "sdDataset": "journals", "sdDatePublished": "2019-03-18T11:05", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "file:///home/ubuntu/piotr/scigraph_export/journals_20190313_sn_only.jsonl", "startYear": "1978", "type": "Periodical", "url": "http://link.springer.com/journal/280" } ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/journal.1088364'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/journal.1088364'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/journal.1088364'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/journal.1088364'


     

    This table displays all metadata directly associated to this object as RDF triples.

    210 TRIPLES      21 PREDICATES      51 URIs      44 LITERALS      31 BLANK NODES

    Subject Predicate Object
    1 sg:journal.1088364 schema:about sg:ontologies/product-market-codes/B11001
    2 sg:ontologies/product-market-codes/B21007
    3 sg:ontologies/product-market-codes/H33160
    4 schema:contentRating N3e6810ec38a74bd0ac87177e2712c563
    5 N497254cdcff9415eba7b97c994b60c22
    6 N5b468e70cd564255848330a18f093f35
    7 N63a3091033ef4d0a85103bd9bb0c8c23
    8 N7bbc5b3fe5d546e9929945e49e5f24f3
    9 N7c1a14c6f5e1499eb99cf592d49462ad
    10 N8504d7d9f8584af18fe5feb4d51e7e14
    11 N850f4d86de98482396a6bbad41d75217
    12 N85575f74da714fba97366344ef0f70c1
    13 Na032a35fccde49eea2450adeef56bc59
    14 Nac4f1168cce6469fbe80d867643ca301
    15 Nadb98d69523c441c836c9722177b79f8
    16 Naef3ff276e944ce58f2fb7a80ba78eec
    17 Nc0d6ef21952346f8a270dfddba43cc9c
    18 Nc9e9d11eb2034fdab5d65faa851fb5e6
    19 Nd0ea6df69d9e4d05b59fb5a32cf8e0f6
    20 Nd29244e8eaa04a6ab5932ff9dc8f68da
    21 Ne596079d57ef4438986f0c339b93fb6a
    22 Ne685aca17b9a4bf6b0ecbe4e362a39c2
    23 Nfc28daa3aa694aca9b97869534c9e8b0
    24 schema:description <p>Cancer Chemotherapy and Pharmacology addresses a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels. The primary focus of this rapid publication medium is on new anticancer agents, their experimental screening, preclinical toxicology and pharmacology, single and combined drug administration modalities, and clinical phase I, II and III trials. </p><p>The journal publishes results recorded in the following areas: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy. Cancer Chemotherapy and Pharmacology is essential reading for pharmacologists and oncologists.</p>
    25 schema:editor N471edded6a694ed39c6533061a27e3d9
    26 schema:inLanguage en
    27 schema:isAccessibleForFree false
    28 schema:issn 0344-5704
    29 1432-0843
    30 schema:license Hybrid (Open Choice)
    31 schema:name Cancer Chemotherapy and Pharmacology
    32 schema:productId N3c433a3fbddb4d7d963cf5d7ef205699
    33 Na3c1c3ec6a38456c809b7a1ac7616139
    34 Na49fc523ea1443a2a3f0c2e1c85002fd
    35 Na501f65752b742768041171902c101c8
    36 Nad2bba97da5541aaa04fba123591dada
    37 Nb0ca6a6753ef4afaa6d2ad7a0a097b14
    38 Nd41755cc73124e1aa87951540d03a21e
    39 Ne98a497b8cbd454d9ba02cae5077347d
    40 schema:publisher N0e1ab4116fbf4aec947cf0ac56f99102
    41 schema:publisherImprint Springer
    42 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1088364
    43 schema:sdDatePublished 2019-03-18T11:05
    44 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    45 schema:sdPublisher N8dfbbbd93d7d439ba1c6cd2d162a7e63
    46 schema:startYear 1978
    47 schema:url http://link.springer.com/journal/280
    48 sgo:license sg:explorer/license/
    49 sgo:sdDataset journals
    50 rdf:type schema:Periodical
    51 N0e1ab4116fbf4aec947cf0ac56f99102 schema:name Springer Berlin Heidelberg
    52 rdf:type schema:Organization
    53 N0e1b2ce38c934a8e9a12abc3773f7e26 rdf:first impact_factor_wos
    54 rdf:rest rdf:nil
    55 N103b3c3c1d794d0dbf817fa6ca9d7923 rdf:first impact_factor_wos
    56 rdf:rest rdf:nil
    57 N276f0018dcd548f3bc43de440996bc48 schema:familyName Sausville
    58 schema:givenName Edward A.
    59 rdf:type schema:Person
    60 N28a531f37c1a4e4e8c5f175ebbdcec3e rdf:first impact_factor_wos
    61 rdf:rest rdf:nil
    62 N30124343fffb42148fd046115a6c5029 rdf:first impact_factor_wos
    63 rdf:rest rdf:nil
    64 N3b1c1732cf3a4360aecb98adbab0afdf rdf:first impact_factor_wos
    65 rdf:rest rdf:nil
    66 N3c433a3fbddb4d7d963cf5d7ef205699 schema:name nsd_ids_id
    67 schema:value 340159
    68 rdf:type schema:PropertyValue
    69 N3e6810ec38a74bd0ac87177e2712c563 schema:author N8b3c0fb0a7384accaca902e3db2b14d2
    70 schema:ratingValue 0.899
    71 rdf:type schema:Rating
    72 N3f858670af4044a59db43068231b9111 rdf:first impact_factor_wos
    73 rdf:rest rdf:nil
    74 N471edded6a694ed39c6533061a27e3d9 rdf:first N276f0018dcd548f3bc43de440996bc48
    75 rdf:rest rdf:nil
    76 N497254cdcff9415eba7b97c994b60c22 schema:author N83b8167af2c445a1b5b41e457d2e9f50
    77 schema:ratingValue 1.147
    78 rdf:type schema:Rating
    79 N4a921f92be40485e91662e8c6ba4eb63 rdf:first impact_factor_wos
    80 rdf:rest rdf:nil
    81 N52fccfbe394342029ae416b25b72fd4c rdf:first impact_factor_wos
    82 rdf:rest rdf:nil
    83 N5b468e70cd564255848330a18f093f35 schema:author N30124343fffb42148fd046115a6c5029
    84 schema:dateCreated 2013
    85 schema:ratingValue 2.571
    86 rdf:type schema:Rating
    87 N63a3091033ef4d0a85103bd9bb0c8c23 schema:author Nfdfe0d4fe0f24da38241ba49d7c02852
    88 schema:dateCreated 2011
    89 schema:ratingValue 2.833
    90 rdf:type schema:Rating
    91 N67a051ddb27a4e789339b3f9994b93ae rdf:first impact_factor_wos
    92 rdf:rest rdf:nil
    93 N7bbc5b3fe5d546e9929945e49e5f24f3 schema:author Nfe19f56b9c604df2a9b860ee21b94e19
    94 schema:dateCreated 2014
    95 schema:ratingValue 2.769
    96 rdf:type schema:Rating
    97 N7c1a14c6f5e1499eb99cf592d49462ad schema:author N52fccfbe394342029ae416b25b72fd4c
    98 schema:dateCreated 2009
    99 schema:ratingValue 2.654
    100 rdf:type schema:Rating
    101 N83b8167af2c445a1b5b41e457d2e9f50 rdf:first sjr
    102 rdf:rest rdf:nil
    103 N8504d7d9f8584af18fe5feb4d51e7e14 schema:author Ndf4c526a8eec4a58981b865153d55d74
    104 schema:dateCreated 2013
    105 schema:ratingValue 2.571
    106 rdf:type schema:Rating
    107 N850f4d86de98482396a6bbad41d75217 schema:author N3f858670af4044a59db43068231b9111
    108 schema:dateCreated 2017
    109 schema:ratingValue 2.808
    110 rdf:type schema:Rating
    111 N85575f74da714fba97366344ef0f70c1 schema:author Naff789822ce24b60931a77133469f564
    112 schema:dateCreated 2012
    113 schema:ratingValue 2.795
    114 rdf:type schema:Rating
    115 N893a927e54754ebe9f74e2a9bd080f8a rdf:first impact_factor_wos
    116 rdf:rest rdf:nil
    117 N8b3c0fb0a7384accaca902e3db2b14d2 rdf:first snip
    118 rdf:rest rdf:nil
    119 N8dfbbbd93d7d439ba1c6cd2d162a7e63 schema:name Springer Nature - SN SciGraph project
    120 rdf:type schema:Organization
    121 Na032a35fccde49eea2450adeef56bc59 schema:author Nba9629facce44c738bc59e5d79ef6dbf
    122 schema:dateCreated 2015
    123 schema:ratingValue 2.824
    124 rdf:type schema:Rating
    125 Na2b6094fc6cc485487716ca1789d27d0 rdf:first impact_factor_wos
    126 rdf:rest rdf:nil
    127 Na3c1c3ec6a38456c809b7a1ac7616139 schema:name wos_id
    128 schema:value 0344-5704/CANCER CHEMOTHERAPY AND PHARMACOLOGY
    129 rdf:type schema:PropertyValue
    130 Na49fc523ea1443a2a3f0c2e1c85002fd schema:name nlm_unique_id
    131 schema:value 7806519
    132 rdf:type schema:PropertyValue
    133 Na501f65752b742768041171902c101c8 schema:name lccn_id
    134 schema:value sn 80001635
    135 rdf:type schema:PropertyValue
    136 Nac4f1168cce6469fbe80d867643ca301 schema:author N28a531f37c1a4e4e8c5f175ebbdcec3e
    137 schema:dateCreated 2015
    138 schema:ratingValue 2.824
    139 rdf:type schema:Rating
    140 Nad2bba97da5541aaa04fba123591dada schema:name scopus_id
    141 schema:value 29097
    142 rdf:type schema:PropertyValue
    143 Nadb98d69523c441c836c9722177b79f8 schema:author N67a051ddb27a4e789339b3f9994b93ae
    144 schema:dateCreated 2010
    145 schema:ratingValue 2.759
    146 rdf:type schema:Rating
    147 Naef3ff276e944ce58f2fb7a80ba78eec schema:author N893a927e54754ebe9f74e2a9bd080f8a
    148 schema:dateCreated 2016
    149 schema:ratingValue 2.737
    150 rdf:type schema:Rating
    151 Naff789822ce24b60931a77133469f564 rdf:first impact_factor_wos
    152 rdf:rest rdf:nil
    153 Nb0ca6a6753ef4afaa6d2ad7a0a097b14 schema:name springer_id
    154 schema:value 280
    155 rdf:type schema:PropertyValue
    156 Nba9629facce44c738bc59e5d79ef6dbf rdf:first impact_factor_wos
    157 rdf:rest rdf:nil
    158 Nc0d6ef21952346f8a270dfddba43cc9c schema:author Na2b6094fc6cc485487716ca1789d27d0
    159 schema:dateCreated 2014
    160 schema:ratingValue 2.769
    161 rdf:type schema:Rating
    162 Nc9e9d11eb2034fdab5d65faa851fb5e6 schema:author Nfa8d543f549d44208fb1aec982f85776
    163 schema:dateCreated 2011
    164 schema:ratingValue 2.833
    165 rdf:type schema:Rating
    166 Nd0ea6df69d9e4d05b59fb5a32cf8e0f6 schema:author N3b1c1732cf3a4360aecb98adbab0afdf
    167 schema:dateCreated 2012
    168 schema:ratingValue 2.795
    169 rdf:type schema:Rating
    170 Nd29244e8eaa04a6ab5932ff9dc8f68da schema:author N4a921f92be40485e91662e8c6ba4eb63
    171 schema:dateCreated 2009
    172 schema:ratingValue 2.654
    173 rdf:type schema:Rating
    174 Nd41755cc73124e1aa87951540d03a21e schema:name era_ids_id
    175 schema:value 14707
    176 rdf:type schema:PropertyValue
    177 Ndf4c526a8eec4a58981b865153d55d74 rdf:first impact_factor_wos
    178 rdf:rest rdf:nil
    179 Ne0536c57ccd44eacb0a33c6391494e28 rdf:first impact_factor_wos
    180 rdf:rest rdf:nil
    181 Ne596079d57ef4438986f0c339b93fb6a schema:author N0e1b2ce38c934a8e9a12abc3773f7e26
    182 schema:dateCreated 2008
    183 schema:ratingValue 2.740
    184 rdf:type schema:Rating
    185 Ne685aca17b9a4bf6b0ecbe4e362a39c2 schema:author Ne0536c57ccd44eacb0a33c6391494e28
    186 schema:dateCreated 2010
    187 schema:ratingValue 2.759
    188 rdf:type schema:Rating
    189 Ne98a497b8cbd454d9ba02cae5077347d schema:name dimensions_id
    190 schema:value 88364
    191 rdf:type schema:PropertyValue
    192 Nfa8d543f549d44208fb1aec982f85776 rdf:first impact_factor_wos
    193 rdf:rest rdf:nil
    194 Nfc28daa3aa694aca9b97869534c9e8b0 schema:author N103b3c3c1d794d0dbf817fa6ca9d7923
    195 schema:dateCreated 2016
    196 schema:ratingValue 2.737
    197 rdf:type schema:Rating
    198 Nfdfe0d4fe0f24da38241ba49d7c02852 rdf:first impact_factor_wos
    199 rdf:rest rdf:nil
    200 Nfe19f56b9c604df2a9b860ee21b94e19 rdf:first impact_factor_wos
    201 rdf:rest rdf:nil
    202 sg:ontologies/product-market-codes/B11001 schema:inDefinedTermSet sg:ontologies/product-market-codes/
    203 schema:name Cancer Research
    204 rdf:type schema:DefinedTerm
    205 sg:ontologies/product-market-codes/B21007 schema:inDefinedTermSet sg:ontologies/product-market-codes/
    206 schema:name Pharmacology/Toxicology
    207 rdf:type schema:DefinedTerm
    208 sg:ontologies/product-market-codes/H33160 schema:inDefinedTermSet sg:ontologies/product-market-codes/
    209 schema:name Oncology
    210 rdf:type schema:DefinedTerm
     




    Preview window. Press ESC to close (or click here)


    ...